• SPX
  • $5,948.71
  • 0.53 %
  • $31.60
  • DJI
  • $43,870.35
  • 1.06 %
  • $461.88
  • N225
  • $38,393.01
  • 0.96 %
  • $366.91
  • FTSE
  • $8,149.27
  • 0.79 %
  • $64.20
  • IXIC
  • $18,972.42
  • 0.03 %
  • $6.28
Sunshine Biopharma, Inc. (SBFM) Stock Price, News & Analysis

Sunshine Biopharma, Inc. (SBFM) Stock Price, News & Analysis

Currency in USD Disclaimer

$2.11

-$0.08

(-3.63%)

Day's range
$2.11
Day's range
$2.2
50-day range
$2.11
Day's range
$3.75
  • Country: CA
  • ISIN: US8677814035
52 wk range
$2.11
Day's range
$638
  • CEO: Dr. Steve N. Slilaty Ph.D.
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -1.12
  • Piotroski Score 2.00
  • Grade N/A
  • Symbol (SBFM)
  • Company Sunshine Biopharma, Inc.
  • Price $2.11
  • Changes Percentage (-3.63%)
  • Change -$0.08
  • Day Low $2.11
  • Day High $2.20
  • Year High $638.00

Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatment compound. It also offers Essential 9, a nutritional supplement tablet; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name, as well as develops and markets other science-based nutritional supplements. The company has a license agreement with the University of Georgia to advance the development of its anti-coronavirus lead compound, SBFM-PL4. Sunshine Biopharma, Inc. is headquartered in Pointe-Claire, Canada.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 03/26/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $554.00
  • Trailing P/E Ratio 0
  • Forward P/E Ratio 0
  • P/E Growth 0
  • Net Income $-4,506,044

Income Statement

Quarterly

Annual

Latest News of SBFM

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Sunshine Biopharma, Inc. Frequently Asked Questions

  • What is the Sunshine Biopharma, Inc. stock price today?

    Today's price of Sunshine Biopharma, Inc. is $2.11 — it has decreased by -3.63% in the past 24 hours. Watch Sunshine Biopharma, Inc. stock price performance more closely on the chart.

  • Does Sunshine Biopharma, Inc. release reports?

    Yes, you can track Sunshine Biopharma, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Sunshine Biopharma, Inc. stock forecast?

    Watch the Sunshine Biopharma, Inc. chart and read a more detailed Sunshine Biopharma, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Sunshine Biopharma, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Sunshine Biopharma, Inc. stock ticker.

  • How to buy Sunshine Biopharma, Inc. stocks?

    Like other stocks, SBFM shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Sunshine Biopharma, Inc.'s EBITDA?

    Sunshine Biopharma, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Sunshine Biopharma, Inc.’s financial statements.

  • What is the Sunshine Biopharma, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -0.1870287568, which equates to approximately -18.70%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Sunshine Biopharma, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Sunshine Biopharma, Inc.'s financials relevant news, and technical analysis. Sunshine Biopharma, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Sunshine Biopharma, Inc. stock currently indicates a “sell” signal. For more insights, review Sunshine Biopharma, Inc.’s technical analysis.

  • A revenue figure for Sunshine Biopharma, Inc. for its last quarter?

    Sunshine Biopharma, Inc. published it's last quarterly revenues at $8.44 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.